Updated Date: Fri, 01 May 2020 00:00:00 EDT

Updated Date: Fri, 01 May 2020 00:00:00 EDT

Updated Date: Fri, 01 May 2020 00:00:00 EDT

Only days after former BARDA chief Rick Bright filed a whistleblower complaint alleging retaliation by the Trump administration, […]

Gilead Sciences has captured worldwide attention with its COVID-19 antiviral, remdesivir, cleared late last week by the FDA—not […]

Scientists have successfully developed a new technique to reliably grow crystals of organic soluble molecules from nanoscale droplets, […]

Unlike its first U.K. reimbursement negotiations, Roche’s HER2 antibody-drug conjugate has won quick National Institute for Health and […]

When Gilead Sciences scored a groundbreaking FDA emergency use authorization for COVID-19 therapy remdesivir, the company made the unusual move […]

Global drugmakers are working overtime to keep supplies coming amid the novel coronavirus pandemic. But in manufacturing facilities […]

Gilead Sciences’ remdesivir, now called Veklury, has won a fast Japanese nod in SARS-CoV-2. The Big Biotech’s scouting […]